NCT02968160View on ClinicalTrials.gov

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

PHASE4TerminatedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions

Metabolic Syndrome

Interventions

DRUG

Telmisartan 40mg + Rosuvastatin 20mg

DRUG

Telmisartan 80mg + Rosuvastatin 20mg

DRUG

Telmisartan 40mg, 80 mg

DRUG

Rosuvastatin 20mg

Trial Locations (1)

10326

Dongguk University Medical Center, Ilsan

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Linical Korea

INDUSTRY

lead

Yuhan Corporation

INDUSTRY